

| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Total Revenue | 511.33 | 465.38 | 350.40 | 218.54 | 126.23 |
| Total Expenses | 328.48 | 290.56 | 281.80 | 175.52 | 101.63 |
| Profit Before Tax | 182.85 | 174.82 | 68.60 | 43.02 | 24.60 |
| Profit After Tax | 138.73 | 133.21 | 50.17 | 33.34 | 18.04 |
| Operating Profit After Depreciation | 188.69 | 178.74 | 70.32 | 43.99 | 25.53 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Fixed Assets | 189.33 | 180.23 | 136.71 | 67.65 | 59.57 |
| Total Non Current Assets | 293.05 | 238.50 | 147.20 | 113.20 | 74.53 |
| Total Current Assets | 424.12 | 275.37 | 196.61 | 99.50 | 56.30 |
| Total Assets | 717.17 | 513.87 | 343.80 | 212.70 | 130.83 |
| Total Shareholder's Fund | 493.09 | 356 | 163.34 | 114.20 | 80.95 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Net Cash From Operating Activities | 48.73 | 65.69 | -2.98 | 35.28 | 9.87 |
| Net Cash Used In Investing Activities | -78.59 | -49.28 | -38.42 | -40.42 | -22.47 |
| Net Cash Used In Financing Activities | 52.70 | -12.74 | 50.92 | 13 | 12.45 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Total Revenue | 365.11 | 351.96 | 415.17 | 353.02 | 221.56 |
| Total Expenses | 235.70 | 219.65 | 324.40 | 282.62 | 176.60 |
| Profit Before Tax | 129.41 | 132.31 | 90.77 | 70.40 | 44.96 |
| Profit After Tax | 95.75 | 98.08 | 67.17 | 52.31 | 34.99 |
| Operating Profit After Depreciation | 134.22 | 135.28 | 94.61 | 72.03 | 45.92 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Fixed Assets | 105.27 | 95.88 | 89.82 | 119.96 | 67.65 |
| Total Non Current Assets | 291.08 | 219.85 | 180.17 | 141.34 | 117.52 |
| Total Current Assets | 313.02 | 230.75 | 235.85 | 191.83 | 96.29 |
| Total Assets | 604.10 | 450.60 | 416.03 | 333.17 | 213.81 |
| Total Shareholder's Fund | 430.12 | 334.60 | 236.88 | 168.24 | 115.93 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Net Cash From Operating Activities | 59.15 | 59.05 | 42.31 | -5.33 | 35.81 |
| Net Cash Used In Investing Activities | -91.59 | -40.67 | -40.71 | -27.97 | -44.71 |
| Net Cash Used In Financing Activities | 54.20 | -16.14 | -10.11 | 39.98 | 13 |
| Particulars (in ₹ Cr.) | 2026-03 | 2025-12 | 2025-09 | 2025-06 | 2025-03 |
|---|---|---|---|---|---|
| Total Revenue | 182.34 | 172.34 | 162.67 | 124.92 | 157.55 |
| Total Expenses | 119.75 | 112.37 | 107.21 | 81.04 | 98.77 |
| Profit Before Tax | 62.69 | 61.78 | 59.54 | 44.08 | 57.86 |
| Profit After Tax | 48.54 | 47.70 | 46.78 | 31.27 | 44.19 |
| Operating Profit after Depreciation | 69.01 | 66.81 | 65.63 | 49.04 | 62.54 |
| Particulars (in ₹ Cr.) | 2026-03 | 2025-12 | 2025-09 | 2025-06 | 2025-03 |
|---|---|---|---|---|---|
| Total Revenue | 80.17 | 90.28 | 87.88 | 80.17 | 104.85 |
| Total Expenses | 51.28 | 60.67 | 57.01 | 49.78 | 59.38 |
| Profit Before Tax | 34.75 | 36.63 | 39.90 | 33.82 | 45.28 |
| Profit After Tax | 25.77 | 26.87 | 29.74 | 25.20 | 33.14 |
| Operating Profit after Depreciation | 38.51 | 39.05 | 43.70 | 37.01 | 48.57 |
| Company | Price | Market Cap (in Cr) |
|---|---|---|
| Sun Pharmaceutical Industries Ltd | ₹1,794.30 | ₹4,30,512.67 |
| Divis Laboratories Ltd | ₹6,651.25 | ₹1,76,569.79 |
| Torrent Pharmaceuticals Ltd | ₹4,570 | ₹1,54,669.57 |
| Cipla Ltd | ₹1,383 | ₹1,11,725.01 |
| Zydus Lifesciences Ltd | ₹1,105.65 | ₹1,11,254.26 |
| Fund Name | AUM |
|---|---|
| SBI Healthcare Opportunities Fund | 2.21% |
| UTI-Healthcare Fund | 1.72% |
| Edelweiss Recently Listed IPO Fund | 1.63% |
| PGIM India Small Cap Fund | 1.14% |
| ICICI Pru MNC Fund | 1.09% |
Of Rs 1.5 per share
22 May 2026, 10:23 am
On 21 May 2026
14 May 2026, 04:14 pm
On 6 February 2026
02 Feb 2026, 05:15 pm
On 19 December 2025
16 Dec 2025, 09:17 am
Shares of Sudeep Pharma were currently trading at Rs 764.05 at 10:20 IST on the BSE, representing a premium of 28.84% as compared with the issue price of Rs 593.
28 Nov 2025, 10:29 am

Get started with us today and
start building your wealth journey
*By clicking, I agree to the T&C and Whatsapp updates.

Get started with us today and
start building your wealth journey
*By clicking, I agree to the T&C and Whatsapp updates.

Congratulations,
Your Digital savings bank account opening journey is complete.